Want a feel-good side gig that requires no work, no skill and no experience? Consider plasma donation through CSL Plasma. It’s a lot like giving blood, but you get paid — sometimes generously. CSL ...

LeAnn Rimes is in a "season of healing" and remains focused on her health in 2026. Following a "busy year of filming and touring," Rimes, 43, cleared her body of "micro-toxins" through a round of ...

As we age, we don’t recover from injury or illness like we did when we were young. But new research from UC San Francisco has found gene regulators that turn genes on and off that could restore the ...

Scientists at China’s Experimental Advanced Superconducting Tokamak (EAST) program rang in the new year with a stunning accomplishment: empirical evidence that they used the device to achieve nuclear ...

The plasma is eventually pushed to a high enough density at the end of startup. The researchers successfully accessed the PWSO theoretical density-free regime, in which the plasma can remain stable ...

The interiors of fusion reactors can get seriously chaotic. But for obvious reasons—like extreme temperatures and pressures—researchers aren’t typically able to peek directly inside a reactor. Some ...

Heart failure occurs when the heart can no longer pump blood efficiently to meet the body’s needs. Beyond weakened muscle cells, new research highlights the hidden role of fibroblasts—supporting cells ...

Plasma (XPL), a blockchain company building stablecoin-focused network, announced a major expansion in Europe to offer regulated payments services. The firm said on Thursday it had acquired a Virtual ...

A laboratory in Troitsk, Russia, may have just nudged humanity closer to interplanetary commuting. Scientists at Rosatom, the country's state nuclear corporation, have revealed a working prototype of ...

The stablecoin-focused Plasma blockchain's native token, XPL, debuted on major exchanges, including Binance and OKX, on Thursday. The token drew a price of up to $1.54 in early trading, resulting in a ...

Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go 'rogue' in many different diseases affecting multiple organs – ...